Effects of intravenous dexmedetomidine on hemodynamic stability, inflammatory factors, and brain injury biomarkers in patients with Moyamoya disease undergoing revascularization surgery

Key Points

• Infusion of dexmedetomidine enhances hemodynamic stability during surgery, which is crucial for patient safety.
• Postoperatively, inflammatory response is decreased, which may improve recovery outcomes for patients.
• Serum levels of S100β, a brain injury biomarker, are significantly lowered, suggesting reduced brain injury risk.
• The intervention indicates that dexmedetomidine may offer protective effects for patients with Moyamoya disease undergoing operations.